E. James Song, MD, FAAD

Discover essential dermatology insights from experts at the Fall Clinical Conference 2025, featuring innovative treatment tips and patient care strategies.

A new IPC-endorsed framework simplifies psoriasis severity into “topical” versus “systemic” categories to guide treatment more effectively, according to James Song, MD.

Song stressed the need for careful therapy selection in patients with comorbid conditions to avoid exacerbating health issues.

E. James Song, MD, FAAD, provides key takeaways on the treatment of patients with plaque psoriasis, highlighting ways to define treatment success and the effect of adverse events on long-term treatment choices.

A dermatologist shares perspectives on patient-specific factors that impact treatment decisions in plaque psoriasis.

An expert on plaque psoriasis provides an overview of systemic therapy options and provides clinical insights on patient monitoring practices and best courses of action when treatment response isn’t sustained.

E. James Song, MD, FAAD, presents a case of a 58-year-old patient with location-specific mild-to-moderate plaque psoriasis.

A dermatologist provides clinical insights on navigating dose escalation and insurance barriers for patients receiving treatment for plaque psoriasis.

Continuing discussion on a case of a 45-year-old patient with plaque psoriasis, E. James Song, MD, FAAD, discusses management strategies for patients with mild-to-moderate plaque psoriasis.

Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.

E. James Song, MD, FAAD, presents the case of a 45-year-old woman with plaque psoriasis who lives in a rural area, introducing a discussion on clinical telemedicine practices.

A dermatologist describes the factors that differentiate plaque psoriasis from other dermatological conditions and how they inform treatment approaches.

E. James Song, MD, FAAD, provides detailed insights on how our understanding of plaque psoriasis has evolved and the ways that has impacted treatment options and decisions.